Janchor Partners
9
140M
8
0.60
2
0.11
2
- Areas of investment
Summary
Janchor Partners is the famous VC, which was founded in 2009. The main office of represented VC is situated in the Central. The venture was found in Asia in Hong Kong.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are PAG, OrbiMed, Heritage Provider Network. In the next rounds fund is usually obtained by PAG, Hudson Bay Capital Management, China Venture Capital.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Alphamab Oncology. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biotechnology.
The top activity for fund was in 2018. The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of more than 100 millions dollars.
This organization was formed by John Ho.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 2
- Exits
- 2
- Rounds per year
- 0.60
- Follow on index
- 0.11
- Investments by industry
- Health Care (5)
- Pharmaceutical (5)
- Biotechnology (5)
- Medical (2)
- Therapeutics (2) Show 5 more
- Investments by region
-
- China (7)
- United States (1)
- India (1)
- Peak activity year
- 2020
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 362M
- Group Appearance index
- 1.00
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MediTrust Health | 10 Aug 2021 | Internet, Health Care, Medical | Late Stage Venture | 308M | Shanghai, Xuhui, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.